Discovery Track corporations are "pre-emerging" biotech and related companies, qualifying as seed and A-round companies that have raised since founding up to $15M through October 2023. For this event, Discovery Track companies must use biotechnology or related technologies to conduct or support research and development of drug products, diagnostics, or digital therapeutics intended for regulatory approval or already under regulatory review.